GlassScriptPhysician profile
Steven T Forman
NPI 1023059763
$15,311.20
in general payments reported to CMS, 2019-2025
48 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,474 · 2020: $2,167 · 2021: $1,477 · 2022: $984 · 2023: $1,466 · 2024: $2,989 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,333.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,882.07 | 2019-2020 | |
| Medtronic, INC. | $2,519.41 | 2021-2025 | Venaseal, Corevalve Evolut R, Micra |
| Novartis Pharmaceuticals Corporation | $1,087.19 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $733.60 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $597.45 | 2019-2023 | Xarelto |
| Amgen INC. | $387.20 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $384.29 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $348.78 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $341.32 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $323.77 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Sentinel |
| Abbott Laboratories | $277.35 | 2021-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Sanofi-Aventis U.S. LLC | $228.41 | 2019-2024 | |
| Edwards Lifesciences Corporation | $216.66 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bard Peripheral Vascular, INC. | $168.37 | 2021-2023 | Venclose Maven Catheter |
| Abiomed | $153.86 | 2021-2025 |
Show all 46 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Forman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.